|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/06 | |
| C07D 239/42 |
| (11) | Number of the document | 1682536 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04768997.1 |
| Date of filing the European patent application | 2004-10-22 | |
| (97) | Date of publication of the European application | 2006-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2004/004481 |
| Date | 2004-10-22 |
| (87) | Number | WO 2005/042522 |
| Date | 2005-05-12 |
| (30) | Number | Date | Country code |
| 0324791 | 2003-10-24 | GB |
| (72) |
OKADA, Tetsuo, Shionogi & Company Limited, JP
HORBURY, John, AstraZeneca, GB
LAFFAN, David Dermot Patrick, AstraZeneca, GB
|
| (73) |
AstraZeneca UK Limited,
2 Kingdom Street, London W2 6BD,
GB
SHIONOGI & CO., LTD., 1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, JP |
| (54) | PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO] PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF |
| PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO] PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF |